Style | Citing Format |
---|---|
MLA | Poustchi H, et al.. "Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening." Archives of Iranian Medicine, vol. 24, no. 3, 2021, pp. 177-186. |
APA | Poustchi H, Alaeishahmiri F, Aghili R, Nobarani S, Malek M, Khamseh ME (2021). Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening. Archives of Iranian Medicine, 24(3), 177-186. |
Chicago | Poustchi H, Alaeishahmiri F, Aghili R, Nobarani S, Malek M, Khamseh ME. "Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening." Archives of Iranian Medicine 24, no. 3 (2021): 177-186. |
Harvard | Poustchi H et al. (2021) 'Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening', Archives of Iranian Medicine, 24(3), pp. 177-186. |
Vancouver | Poustchi H, Alaeishahmiri F, Aghili R, Nobarani S, Malek M, Khamseh ME. Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening. Archives of Iranian Medicine. 2021;24(3):177-186. |
BibTex | @article{ author = {Poustchi H and Alaeishahmiri F and Aghili R and Nobarani S and Malek M and Khamseh ME}, title = {Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening}, journal = {Archives of Iranian Medicine}, volume = {24}, number = {3}, pages = {177-186}, year = {2021} } |
RIS | TY - JOUR AU - Poustchi H AU - Alaeishahmiri F AU - Aghili R AU - Nobarani S AU - Malek M AU - Khamseh ME TI - Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening JO - Archives of Iranian Medicine VL - 24 IS - 3 SP - 177 EP - 186 PY - 2021 ER - |